Edition:
United States

Bioblast Pharma Ltd (ORPN.OQ)

ORPN.OQ on NASDAQ Stock Exchange Capital Market

1.81USD
22 Jun 2018
Change (% chg)

$0.09 (+5.23%)
Prev Close
$1.72
Open
$1.76
Day's High
$1.81
Day's Low
$1.68
Volume
5,752
Avg. Vol
17,931
52-wk High
$5.99
52-wk Low
$1.64

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Dec '17 0.00 -0.170
Sep '17 0.00 -0.320
Jun '17 0.00 -0.496
Mar '17 0.00 -0.815
FY 2016 Dec '16 0.00 -0.939
Sep '16 0.00 -1.424
Jun '16 0.00 -1.124
Mar '16 0.00 -1.588
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 248.83 34.14
P/E High - Last 5 Yrs. -- 293.42 47.76
P/E Low - Last 5 Yrs. -- 100.49 25.04
Beta 0.54 0.74 0.78
Price to Sales (TTM) -- 246.52 8.17
Price to Book (MRQ) 1.91 23.99 4.30
Price to Tangible Book (MRQ) 1.91 30.50 6.00
Price to Cash Flow (TTM) -- 145.85 22.70
% Owned Institutions 18.67 11.95 2.44

Dividends

  Company industry sector
Dividend Yield -- 0.33 1.70
Dividend Yield - 5 Year Avg -- 0.20 1.43
Dividend 5 Year Growth Rate -- 2.19 -6.26
Payout Ratio(TTM) -- 41.90 42.76

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 27.24 5.16
Sales (TTM) vs TTM 1 Yr. Ago -- 139.74 13.40
Sales - 5 Yr. Growth Rate -- 31.45 7.89
EPS (MRQ) vs Qtr. 1 Yr. Ago 81.87 -84.38 39.68
EPS (TTM) vs TTM 1 Yr. Ago 64.49 -- --
EPS - 5 Yr. Growth Rate -- 49.40 8.05
Capital Spending - 5 Yr. Growth Rate -- 37.00 7.35

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.67 2.55
Current Ratio (MRQ) 7.87 6.39 3.63
LT Debt to Equity (MRQ) 0.00 22.27 13.12
Total Debt to Equity (MRQ) 0.00 26.58 17.55
Interest Coverage (TTM) -- -141.36 36.62

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.61 55.11
Gross Margin - 5 Yr. Avg. -- 55.12 52.97
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -170.99 15.68
Operating Margin (TTM) -- -889.67 -0.25
Operating Margin - 5 Yr. Avg. -- -184.49 10.87
Pre-Tax Margin (TTM) -- -784.00 1.68
Pre-Tax Margin - 5 Yr. Avg. -- -188.52 11.03
Net Profit Margin (TTM) -- -777.70 -1.61
Net Profit Margin - 5 Yr. Avg. -- -187.13 7.38
Effective Tax Rate (TTM) -- 15.50 29.97
Effective Tax Rate - 5 Yr. Avg. -- 19.39 24.15

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 22,135,587 727,159,976
Net Income/Employee (TTM) -- -51,964 84,694,665
Receivable Turnover (TTM) -- 18.41 6.01
Inventory Turnover (TTM) -- 2.85 3.67
Asset Turnover (TTM) 0.00 0.48 0.87

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -83.43 -3.55 10.32
Return on Assets - 5 Yr. Avg. -68.63 -0.74 10.99
Return on Investment (TTM) -100.24 -5.25 13.10
Return on Investment - 5 Yr. Avg. -76.90 2.09 14.28
Return on Equity (TTM) -100.24 -6.83 15.09
Return on Equity - 5 Yr. Avg. -77.03 -2.95 15.63
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 64.38 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Bioblast Pharma Ltd

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 18.67%
# of Holders: 5
Total Shares Held: 624,191
3 Mo. Net Change: 21,726
# New Positions: 0
# Closed Positions: 0
# Increased Positions: 3
# Reduced Positions: 0
# Net Buyers: 3
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.